Boule Diagnostics AB (BOUL.ST)
27 Feb 2015
* Q4 net sales 90.1 million Swedish crowns ($10.70 million) versus 72.2 million crowns year ago
* Has won the procurement of instruments for blood cell counting in primary care in Östergötland
* Says the instruments will gradually replace the existing products under the brands Medonic and Swelab
* Q3 operating profit 10.0 million Swedish crowns versus loss 91.7 million crowns
Earnings vs. Estimates
Analyst Research Reports
Boule Diagnostics AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.